Sangart Initiates Phase 2b Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrh... ( SAN DIEGO June 14 2011 /- Sangart Inc...)

Sangart Initiates Phase 2b Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock

Date:6/14/2011

SAN DIEGO, June 14, 2011 /PRNewswire/ -- Sangart, Inc., a global biopharmaceutical company dedicated to developing life-saving medicines specifically designed to enhance the perfusion and oxygenation of ischemic (oxygen deprived) tissues through targeted oxygen and other gas delivery, today announced the initiation of a Phase 2b study designed to evaluate the efficacy and safety of MP4OX treatment plus standard of care in severely injured trauma patients with lactic acidosis due to hemorrhagic shock. MP4OX is a novel oxygen therapeutic agent that is designed to provide rapid oxygen delivery to ischemic tissues.

"Based on results from the preclinical and Phase 2a studies, MP4OX has shown its potential in improving outcomes in bleeding trauma patients," said Karim Brohi, Professor of Trauma Sciences at the Royal London Hospital. "These studies have shown that MP4OX may increase the delivery of oxygen to the body and prevent organs from failing when a patient is experiencing hemorrhagic shock. This trial initiation is a key phase in finding a treatment that can improve patient outcomes after major trauma."

The clinical trial is a multi-center, randomized, double-blind, controlled study that will enroll approximately 360 patients who have suffered hemorrhagic shock with lactic acidosis across approximately 50 trial sites in 15 countries. The primary objective of the study is to measure the proportion of patients discharged alive from the hospital, as well as a number of secondary endpoints including lactic acidosis resolution. The dosing regimen in this study will include an initial dose of 250 mL of MP4OX plus up to three replacement doses of 250 mL each, all within 12 hours following the initial dose.

"The initiation of this study is another important step in bringing MP4OX to patients with medical conditions that deprive tissue of necessary oxygen," said Brian O'Callaghan, President and CEO of Sangart. "We remain committed to developing
'/>"/>

SOURCE Sangart, Inc.
Copyright©2010 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3
Related medicine technology :

1. Sangart Announces Closing of $50 Million Series G Financing
2. Sangart, Inc. Receives U.S. Orphan Drug Designation for use of MP4CO in Patients with Sickle Cell Disease
3. Sangart, Inc. Initiates Phase IIa Study of Oxygen Therapeutic Agent MP4OX in Severe Trauma Patients With Hemorrhagic Shock
4. Sangart Completes Enrollment in Phase III Study of Its Novel Blood Substitute Hemospan
5. Independent Data Safety Monitoring Board Recommends Continuation of Sangarts Pivotal Phase III Trials of Hemospan(R) Following Second Interim Review
6. Sangart, Inc. Initiates Dosing in Phase II Study of Hemospan(R) in Chronic Critical Limb Ischemia
7. Masimo Initiates Limited Market Release of E1, Single-Patient-Use Ear Sensor for Pulse Oximetry Monitoring
8. Tigris Pharmaceuticals Initiates Randomized Phase 2 Study of AFP-464 in ER-Positive Breast Cancer Patients
9. American Regent Initiates Nationwide Voluntary Recall of Sterile Water for Injection, USP, 50 mL Single Dose Vial Due to Particulate Matter
10. ViroPharma Initiates Phase 2 Study of VP 20621 for Prevention of Recurrence of Clostridium difficile Infection (CDI)
11. BAETA Corp Initiates Clinical Trial at NYU School of Medicine to Measure Efficacy of Pain Recording Device

Post Your Comments:

(Date:5/17/2013)... , May 17, 2013 Sony Biotechnology Inc. ... SP6800 Spectral Analyzer (SP6800). Sony will be exhibiting and ... will be held at the San Diego ... California , from May 20 - 22. ... analytical system, incorporating commercial audio-visual technologies into new and ...

(Date:5/17/2013)... , May 17, 2013 /PRNewswire-iReach/ -- The escalation ... proteins, is placing renewed emphasis on alternate delivery ... as a number of factors are converging to ... makers and their delivery device partners . These ... conditions, the growing trend toward self-administration for chronic ...

(Date:5/17/2013)... 2013 Atossa Genetics, Inc. (NASDAQ: ATOS ), ... Guse , Chief Financial Officer & General Counsel, will ... Thursday, May 30, 2013, in New York City ... The Company,s presentation is scheduled to begin at 3:30 p.m. ... access the webcast, go to www.atossagenetics.com . ...

Breaking Medicine Technology:Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color 2 Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 2 Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment 3 Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 2 Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference 3

[0] Sony Biotechnology Inc.'s New Technology for Science Provides Researchers Results in Color [0] Pharmaceutical Makers and Delivery Device Partners Rethink Delivery Technologies - New Report Examines this Evolving Segment [0] Atossa Genetics to Present at the Second Annual Marcum LLP MicroCap Conference

... Oxygen Biotherapeutics, Inc. (OTC Bulletin Board: OXBT) today announced ... addition of Lt. Gen. Ronald R. Blanck, DO, U.S. Army ... a federal health services consulting firm based in Falls Church, ... members. , Dr. Blanck began his military career in 1968 ...

... MORRISTOWN, N.J., Dec. 14 Watson Pharmaceuticals, Inc. (NYSE: ... professionals to help maintain the bone health of prostate cancer ... Nearly two million men are receiving ADT, a palliative treatment ... "gold therapy," can cause bone loss and increase a man,s ...

Cached Medicine Technology:Oxygen Biotherapeutics, Inc. Expands Board of Directors 2 Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 2 Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 3 Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 4 Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy 5

Oxygen Biotherapeutics, Inc. Expands Board of Directors Watson Announces New Program to Help Promote Good Bone Health in Advanced Prostate Cancer Patients on Long-Term Androgen Deprivation Therapy

(Date:5/19/2013)... 19, 2013 Fat Burning Furnace developed ... that provides people with fat burning diet ... this Fat Burning Furnace package, people will receive the ... can download quickly. The Fat Burning Furnace manual includes ... build lean muscle mass. In addition, this book covers ...

(Date:5/19/2013)... May 19, 2013 Farming methods have ... in the ground 10,000 years ago. Most recently, the ... productivity by using genetically engineered seeds and by applying ... a backlash to these techniques due to the adverse ... and a corresponding surge in interest in organic, sustainable ...

(Date:5/19/2013)... Nevada (PRWEB) May 19, 2013 Vegas ... , is proud to announce the launch it's all ... at the MGM Grand on 5/19/2013. Consumers traveling to ... new special pricing available on VegasHotelEscapes.com's website. Travelers will ... they beat any competitors price. , Vegas Hotel Escapes ...

(Date:5/19/2013)... Exciting new Skin Brushes are available from ... practice known through the ages but is a lost ... brushing, has so many benefits for our health and ... love that circulation and lymphatic systems get a boost ... is supported through Skin Brushing." , Why is Skin ...

(Date:5/19/2013)... Buenos Aires, Argentina: Yoga classes ( clases ... Aires, Argentina by the Sivananda Yoga Vedanta Center. ... - (Barrio Norte). Classes are 90 minutes and are ... offered in a calm environment, allowing visitors to enjoy ... vegetarian food, among others. , The Yoga classes follow ...

Breaking Medicine News(10 mins):Health News:Fat Burning Diet | How “Fat Burning Furnace” Helps People Lose Their Weight Naturally And Fast – V-kool 2 Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 2 Health News:Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics 3 Health News:Exciting New Skin Brushes at Sublime Beauty® Bring Health and Beauty Benefits; Celebrities and Models Know the Secret 2 Health News:Clases de Yoga in Buenos Aires, Argentina (Yoga Classes) Now Offered by Sivananda Yoga Vedanta Center 2

[0] Fat Burning Diet | How “Fat Burning Furnace” Helps People Lose Their Weight Naturally And Fast – V-kool [0] Green Acre Aquaponics Introduces a Revolutionary Approach to Farm Education and Commercial Aquaponics [0] VegasHotelEscapes.com Announces Special Vegas Packages For Billboard Music Awards [0] Exciting New Skin Brushes at Sublime Beauty® Bring Health and Beauty Benefits; Celebrities and Models Know the Secret [0] Clases de Yoga in Buenos Aires, Argentina (Yoga Classes) Now Offered by Sivananda Yoga Vedanta Center

... NEW YORK, Nov. 9 China,s,largest drugstore chain ... Nepstar Chain Drugstore Ltd (NYSE: NPD ) ... New York Stock Exchange. Nepstar offered 20,625,000 ... at US$16.20 each. Gross proceeds from the offering,not ...

... to teach children that trains and railroad tracks,may be dangerous ... railroads,in North America, are launching Safe Crossing Week, Nov 12-18, ... of 916 people are killed and,8,300 are seriously injured in ... of 39 children aged 15 and under were killed in ...

... Funding is Critical for Research, Treatment and Disease ... ALEXANDRIA, Va., Nov. 9 The American,Diabetes Association ... Labor,HHS Appropriations bill which will help provide for ... diabetes. Nearly 21 million children and,adults are affected ...

... MD. The AUA is pleased to announce their new ... Each year, more than 60,000 people are diagnosed with ... of risk factors, including cigarette smoking and exposure to ... 1999 and the report issued today is an update ...

... rise, doctors in this weeks BMJ report three cases of ... pain. , Although rare, this condition has previously only been ... is costing the NHS up to 3bn a year, with ... and 22,000 premature deaths each year caused by problems related ...

... Preliminary Information on Recapitalizations, Asset Sales and ... Anticipated Pre-Tax Charges ... Accounting Restatement, MCLEAN, Va., Nov. 9 Sunrise Senior Living,Inc. (NYSE: ... quarter ended September 30, 2007. The Company also,provided preliminary information on recapitalizations, ...

China Nepstar Chain Drugstore (NPD) Begins Trading on NYSE Safe Crossing Week 2007 Teaches Kids How to Behave Safely Around Trains ADA Urges President Bush Not to Veto Critical Appropriations Bill AUA releases new guidelines on non-muscle invasive bladder cancer Warning for women who binge drink Sunrise Reports Preliminary Selected Financial and Operating Data for Third-Quarter 2007

... is the perfect partner for growing your ... are scalable to meet your needs now ... that your Allura Xper FD20 system supports ... Openness to new technologies allows you to ...

... Lesions ,Designed for the treatment of ... is a powerful ablation-only catheter. This 9 ... was designed to provide maximum cryo performance. ... as the other cryocatheters, but its larger ...

... slices, changes the way anatomy is imaged ... VCT Series of scanners combine superior resolution ... difficult patients or procedures more routine., The ... door to new procedures while improving the ...

... on the Alpha 5 include a newly ... digital processor specifically designed for ultrasonic signals. ... reduces image speckle and enables clearer imaging ... The enhanced user confidence afforded by Alpha ...

Medicine Products:

Allura Xper FD20 for Interventional Cardiology Freezor MAX LightSpeed VCT 64-slice Scanner Prosound Alpha-5